JPH10175868A - Water (of chinese medicine idea) improving composition - Google Patents
Water (of chinese medicine idea) improving compositionInfo
- Publication number
- JPH10175868A JPH10175868A JP26052497A JP26052497A JPH10175868A JP H10175868 A JPH10175868 A JP H10175868A JP 26052497 A JP26052497 A JP 26052497A JP 26052497 A JP26052497 A JP 26052497A JP H10175868 A JPH10175868 A JP H10175868A
- Authority
- JP
- Japan
- Prior art keywords
- action
- skin
- saccharide
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 49
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title abstract description 16
- 239000003814 drug Substances 0.000 title abstract description 15
- 230000009471 action Effects 0.000 claims abstract description 36
- 230000001737 promoting effect Effects 0.000 claims abstract description 29
- 150000002632 lipids Chemical class 0.000 claims abstract description 26
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 23
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 10
- 239000008103 glucose Substances 0.000 claims abstract description 10
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims abstract description 8
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 6
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 claims abstract description 5
- ASJSAQIRZKANQN-CRCLSJGQSA-N 2-deoxy-D-ribose Chemical compound OC[C@@H](O)[C@@H](O)CC=O ASJSAQIRZKANQN-CRCLSJGQSA-N 0.000 claims abstract description 5
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims abstract description 5
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims abstract description 5
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims abstract description 5
- HMFHBZSHGGEWLO-SOOFDHNKSA-N D-ribofuranose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H]1O HMFHBZSHGGEWLO-SOOFDHNKSA-N 0.000 claims abstract description 5
- 239000005715 Fructose Substances 0.000 claims abstract description 5
- 229930091371 Fructose Natural products 0.000 claims abstract description 5
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims abstract description 5
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims abstract description 5
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229930195725 Mannitol Natural products 0.000 claims abstract description 5
- PYMYPHUHKUWMLA-LMVFSUKVSA-N Ribose Natural products OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-LMVFSUKVSA-N 0.000 claims abstract description 5
- 229930006000 Sucrose Natural products 0.000 claims abstract description 5
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 5
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 claims abstract description 5
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 claims abstract description 5
- HMFHBZSHGGEWLO-UHFFFAOYSA-N alpha-D-Furanose-Ribose Natural products OCC1OC(O)C(O)C1O HMFHBZSHGGEWLO-UHFFFAOYSA-N 0.000 claims abstract description 5
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 claims abstract description 5
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 claims abstract description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims abstract description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000013681 dietary sucrose Nutrition 0.000 claims abstract description 5
- 229930182830 galactose Natural products 0.000 claims abstract description 5
- 239000000594 mannitol Substances 0.000 claims abstract description 5
- 235000010355 mannitol Nutrition 0.000 claims abstract description 5
- 239000000600 sorbitol Substances 0.000 claims abstract description 5
- 229960004793 sucrose Drugs 0.000 claims abstract description 5
- 206010012438 Dermatitis atopic Diseases 0.000 claims description 20
- 201000008937 atopic dermatitis Diseases 0.000 claims description 20
- 230000003779 hair growth Effects 0.000 claims description 12
- 208000017520 skin disease Diseases 0.000 claims description 12
- 239000004480 active ingredient Substances 0.000 claims description 8
- 239000003788 bath preparation Substances 0.000 claims description 8
- 238000002360 preparation method Methods 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 7
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 230000001225 therapeutic effect Effects 0.000 claims description 5
- 230000002500 effect on skin Effects 0.000 claims description 4
- 150000002339 glycosphingolipids Chemical class 0.000 claims description 4
- 235000010356 sorbitol Nutrition 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 2
- 150000003019 phosphosphingolipids Chemical class 0.000 claims description 2
- 230000003449 preventive effect Effects 0.000 claims 1
- 230000028327 secretion Effects 0.000 abstract description 11
- 210000000056 organ Anatomy 0.000 abstract description 3
- 230000004936 stimulating effect Effects 0.000 abstract description 2
- 230000001276 controlling effect Effects 0.000 abstract 1
- 230000000694 effects Effects 0.000 description 33
- 239000000839 emulsion Substances 0.000 description 11
- 210000003491 skin Anatomy 0.000 description 11
- 201000004624 Dermatitis Diseases 0.000 description 8
- 208000012641 Pigmentation disease Diseases 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 7
- 208000010668 atopic eczema Diseases 0.000 description 6
- 239000013040 bath agent Substances 0.000 description 6
- 230000019612 pigmentation Effects 0.000 description 6
- 208000007163 Dermatomycoses Diseases 0.000 description 5
- 201000004681 Psoriasis Diseases 0.000 description 5
- 206010039796 Seborrhoeic keratosis Diseases 0.000 description 5
- 208000000260 Warts Diseases 0.000 description 5
- 206010048218 Xeroderma Diseases 0.000 description 5
- 201000003929 dermatomycosis Diseases 0.000 description 5
- 230000001079 digestive effect Effects 0.000 description 5
- 206010021198 ichthyosis Diseases 0.000 description 5
- 201000010153 skin papilloma Diseases 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 235000000346 sugar Nutrition 0.000 description 5
- 238000012360 testing method Methods 0.000 description 5
- JSPNNZKWADNWHI-PNANGNLXSA-N (2r)-2-hydroxy-n-[(2s,3r,4e,8e)-3-hydroxy-9-methyl-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]heptadecanamide Chemical compound CCCCCCCCCCCCCCC[C@@H](O)C(=O)N[C@H]([C@H](O)\C=C\CC\C=C(/C)CCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O JSPNNZKWADNWHI-PNANGNLXSA-N 0.000 description 4
- 229930183167 cerebroside Natural products 0.000 description 4
- RIZIAUKTHDLMQX-UHFFFAOYSA-N cerebroside D Natural products CCCCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=C(C)CCCCCCCCC)COC1OC(CO)C(O)C(O)C1O RIZIAUKTHDLMQX-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000001882 diuretic effect Effects 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 238000010438 heat treatment Methods 0.000 description 3
- 241000411851 herbal medicine Species 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 239000000243 solution Substances 0.000 description 3
- 210000004243 sweat Anatomy 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- WWUZIQQURGPMPG-UHFFFAOYSA-N (-)-D-erythro-Sphingosine Natural products CCCCCCCCCCCCCC=CC(O)C(N)CO WWUZIQQURGPMPG-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 206010015150 Erythema Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 210000002615 epidermis Anatomy 0.000 description 2
- 231100000321 erythema Toxicity 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 230000037380 skin damage Effects 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- WWUZIQQURGPMPG-KRWOKUGFSA-N sphingosine Chemical compound CCCCCCCCCCCCC\C=C\[C@@H](O)[C@@H](N)CO WWUZIQQURGPMPG-KRWOKUGFSA-N 0.000 description 2
- 150000005846 sugar alcohols Chemical class 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- PORPENFLTBBHSG-MGBGTMOVSA-N 1,2-dihexadecanoyl-sn-glycerol-3-phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(O)=O)OC(=O)CCCCCCCCCCCCCCC PORPENFLTBBHSG-MGBGTMOVSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- AJBZENLMTKDAEK-UHFFFAOYSA-N 3a,5a,5b,8,8,11a-hexamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-4,9-diol Chemical compound CC12CCC(O)C(C)(C)C1CCC(C1(C)CC3O)(C)C2CCC1C1C3(C)CCC1C(=C)C AJBZENLMTKDAEK-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 244000080767 Areca catechu Species 0.000 description 1
- 238000011735 C3H mouse Methods 0.000 description 1
- 235000003880 Calendula Nutrition 0.000 description 1
- 240000001432 Calendula officinalis Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 235000009917 Crataegus X brevipes Nutrition 0.000 description 1
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 description 1
- 235000009685 Crataegus X maligna Nutrition 0.000 description 1
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 description 1
- 235000009486 Crataegus bullatus Nutrition 0.000 description 1
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 description 1
- 235000009682 Crataegus limnophila Nutrition 0.000 description 1
- 235000004423 Crataegus monogyna Nutrition 0.000 description 1
- 240000000171 Crataegus monogyna Species 0.000 description 1
- 235000002313 Crataegus paludosa Nutrition 0.000 description 1
- 235000009840 Crataegus x incaedua Nutrition 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 206010051814 Eschar Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 244000299790 Rheum rhabarbarum Species 0.000 description 1
- 235000009411 Rheum rhabarbarum Nutrition 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical group [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- ATBOMIWRCZXYSZ-XZBBILGWSA-N [1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexadecanoyloxypropan-2-yl] (9e,12e)-octadeca-9,12-dienoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(COP(O)(=O)OCC(O)CO)OC(=O)CCCCCCC\C=C\C\C=C\CCCCC ATBOMIWRCZXYSZ-XZBBILGWSA-N 0.000 description 1
- 208000020560 abdominal swelling Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 239000002390 adhesive tape Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- AWUCVROLDVIAJX-UHFFFAOYSA-N alpha-glycerophosphate Natural products OCC(O)COP(O)(O)=O AWUCVROLDVIAJX-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 229940005513 antidepressants Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 210000000476 body water Anatomy 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- -1 carbon sugars Chemical class 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 150000008266 deoxy sugars Chemical class 0.000 description 1
- 230000000994 depressogenic effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940105990 diglycerin Drugs 0.000 description 1
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 231100000333 eschar Toxicity 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 150000002270 gangliosides Chemical class 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000002262 irrigation Effects 0.000 description 1
- 238000003973 irrigation Methods 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 239000009538 yokuinin Substances 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Cosmetics (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、津液作用の改善に
有益な化粧料、浴用剤及び皮膚外用医薬品等の津液改善
組成物に関する。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a composition for improving a tanning solution, such as a cosmetic, a bath preparation, and a medicine for external use on the skin, which is useful for improving the effect of a tanning solution.
【0002】[0002]
【従来の技術】漢方思想における気、血、水の考え方
は、その薬理作用の捉え方のユニークさと、漢方薬選択
時の合理的な指標であるために、古くより研究されてき
た。これらの内、気、血の意味するものについては、多
くのことが解明されてきた。例えば、血とは酸素、栄養
等エネルギーを中心とする補給・代謝を表すキーワード
であり、気とは生命活動の恒常性機構の活動状況と生命
活動の原動力の状況を表すキーワードであることが知ら
れている。2. Description of the Related Art The concept of qi, blood, and water in Chinese medicine has long been studied because of its uniqueness in understanding its pharmacological action and a rational index for selecting Chinese medicine. Of these, many have been elucidated about the meanings of qi and blood. For example, it is known that blood is a keyword that represents the supply and metabolism mainly of energy such as oxygen and nutrition, and ki is a keyword that represents the status of the homeostasis of life activity and the status of the driving force of life activity. Have been.
【0003】しかし、水(津液)の働きについては老廃
物の代謝・排泄作用のみしか知られておらず、気・血・
水の論理体型において遅れて認識された為、その真の作
用(津液作用)の解明は未完であった。また、津液作用
と現代医学で認識されている種々の薬理作用等との関係
や津液の現代医学における役割などはあまり知られてお
らず、現代医学の分野における津液作用の解明及び津液
作用の改善をもたらす化粧料、医薬品等の組成物の開発
が望まれていた。[0003] However, only the metabolism and excretion of waste products is known for the function of water (tsu liquor).
Since the recognition was delayed in the logical form of water, the elucidation of its true action (Tsukumi action) was incomplete. Also, little is known about the relationship between the pulp action and the various pharmacological actions recognized in modern medicine, and the role of pulp in modern medicine. There has been a demand for the development of compositions such as cosmetics and pharmaceuticals that bring about the following.
【0004】[0004]
【発明が解決しようとする課題】本発明はこのような状
況を踏まえてなされたものであり、津液の真の作用を明
らかにし、津液作用の改善に用いられる皮膚外用剤等の
津液改善組成物を提供することを課題とする。DISCLOSURE OF THE INVENTION The present invention has been made in view of such circumstances, and clarifies the true function of a tsuju. The task is to provide
【0005】[0005]
【課題を解決するための手段】本発明者等は、このよう
な状況に鑑み、津液の真の作用を求めて鋭意研究を重ね
た結果、津液作用が、ある種の物質の働きによって水分
の体外への分泌を司る器官を刺激し、体内水分の体外へ
の分泌を促進させる作用を意味していることを見いだし
た。そして、そのような分泌器官を刺激し津液作用を促
進・改善しうる物質について検討した結果、本発明を完
成した。Means for Solving the Problems In view of such a situation, the present inventors have conducted intensive studies in search of the true function of tsuju. It was found that it stimulates the organs responsible for extracorporeal secretion and promotes the secretion of body water out of the body. Then, as a result of examining substances capable of stimulating such secretory organs and promoting / improving the action of the pulp, the present invention was completed.
【0006】すなわち、本発明は、糖類と生体親和性脂
質とを有効成分とする、津液作用の改善に用いられる津
液改善組成物を提供するものである。また、本発明は、
糖類と生体親和性脂質とを有効成分とする、皮膚疾患治
療又は予防用組成物を提供するものである。[0006] That is, the present invention provides a tsunami-improving composition which comprises a saccharide and a biocompatible lipid as active ingredients and which is used for improving the effect of tsunami. Also, the present invention
An object of the present invention is to provide a composition for treating or preventing a skin disease, comprising a saccharide and a biocompatible lipid as active ingredients.
【0007】本発明者らは、津液作用が、真皮から表皮
への水分分泌を促進し表皮に十分な水分を保持させるこ
とによって起こる美肌作用、アトピー性皮膚炎、湿疹、
皮膚真菌症、疣贅、色素沈着症、尋常性乾癬、老人性乾
皮症、老人性角化腫、火傷等の各種皮膚疾患治療作用、
発毛促進作用、発汗促進作用、胃壁、腎臓、腸管での水
分分泌を促進させることによって起こる消化液分泌促進
作用、利尿作用、便通促進作用にかかわる作用であるこ
とを見出した。[0007] The present inventors have found that the essence of the tanning solution, which promotes the secretion of water from the dermis to the epidermis and causes the epidermis to retain sufficient moisture, atopic dermatitis, eczema,
Dermatomycosis, warts, pigmentation, psoriasis vulgaris, senile xeroderma, senile keratoma, therapeutic effects on various skin diseases such as burns,
It has been found that the action is related to a hair growth promoting action, a sweat promoting action, a digestive juice secretion promoting action, a diuretic action and a bowel movement promoting action caused by promoting water secretion in the stomach wall, kidney and intestinal tract.
【0008】すなわち、漢方生薬の薬効分類を詳細に検
討し、現代医薬分類との対比を行った結果、水(津液)
が関与すると言われている、しゃ下、利水、消導、補陰
と言った薬草群の作用が現代医薬品分類における美肌作
用、アトピー性皮膚炎治療作用、湿疹で代表される皮膚
炎群治療作用、皮膚真菌症治療作用、疣贅治療作用、肝
炎で代表される色素沈着症治療作用、尋常性乾癬治療
症、老人性乾皮症、老人性角化腫治療作用、物理的原因
による皮膚損傷治療作用、発毛促進作用、消化液分泌促
進作用、発汗促進作用、利尿作用、便通促進作用と係わ
りが深いことを見いだした。[0008] That is, the medicinal classification of Chinese herbal medicines was examined in detail, and compared with modern medicine classifications.
It is said that the effects of the herbs such as shampoo, irrigation, conduction and prosthesis are related to beautiful skin effect, atopic dermatitis treatment, and dermatitis group treatment represented by eczema in the modern pharmaceutical classification. , Dermatomycosis treatment, wart treatment, pigmentation such as hepatitis, psoriasis vulgaris, senile xeroderma, senile keratoma treatment, skin damage treatment due to physical causes It has been found that it is closely related to the action, the hair growth promoting action, the digestive juice secretion promoting action, the sweating promoting action, the diuretic action and the bowel movement promoting action.
【0009】この知見をもとに種々の物質について美肌
作用、アトピー性皮膚炎治療作用、発毛促進作用、湿疹
の治療作用、消化液分泌促進作用、発汗促進作用を指標
にスクリーニングを重ねたところ、グルコース、ガラク
トース、フルクトース、マンニトール、ソルビトール、
トレハロース、サッカロース、アラビノース、リボー
ス、デオキシリボース、ラムノース、グリセリン等の糖
類と燐脂質、スフィンゴ燐脂質、スフィンゴ糖脂質等の
生体親和性脂質とを組み合わせた組成物がこのような作
用に優れることを見いだした。さらに、これらの組成物
の皮膚外用的投与が、津液不全による前述の疾患の内、
取り分けアトピー性皮膚炎等の皮膚疾患の治療・予防に
効果的であることを見出し、本発明を完成させるに至っ
た。Based on this finding, screening was carried out on various substances based on their beautifying effect, therapeutic effect on atopic dermatitis, promoting hair growth, treating eczema, promoting secretion of digestive juice, and promoting sweating. , Glucose, galactose, fructose, mannitol, sorbitol,
It has been found that a composition in which a saccharide such as trehalose, saccharose, arabinose, ribose, deoxyribose, rhamnose, and glycerin is combined with a biocompatible lipid such as phospholipid, sphingolipid, and glycosphingolipid is excellent in such action. Was. In addition, topical administration of these compositions to the skin may cause the above-mentioned diseases caused by insufficiency of tsuchu,
In particular, they have found that they are effective in treating and preventing skin diseases such as atopic dermatitis, and have completed the present invention.
【0010】グルコース等の糖類と燐脂質等の生体親和
性脂質とを組み合わせた組成物が津液作用を改善させる
作用に優れることは全く知られていなかった。また、こ
れにより、例えば、アトピー性皮膚炎などの種々の皮膚
疾患を著しく改善する効果が得られることも全く知られ
ていなかった。[0010] It has never been known that a composition comprising a combination of a saccharide such as glucose and a biocompatible lipid such as a phospholipid is excellent in the effect of improving the pulp action. Also, it was not known at all that, for example, an effect of remarkably improving various skin diseases such as atopic dermatitis was obtained.
【0011】[0011]
【発明の実施の形態】以下に、本発明の実施の形態を説
明する。本発明の津液改善組成物は、糖類と生体親和性
脂質とを有効成分として含有することを特徴とする。こ
こで糖類は、一般的に知られている糖類であればよく、
例えば、グルコース、ガラクトース、フルクトース、ア
ラビノース、リボース等の3〜6炭糖やこれらの誘導
体、具体的には、マンニトール、ソルビトール、グリセ
リン等の糖アルコール、デオキシリボース、ラムノース
等のデオキシ糖、グルコサミン等のアミノ糖、グルクロ
ン酸やグルコン酸等のカルボキシル基を有する糖等を含
む単糖類、又はこれらの1種又は複数の組み合わせの脱
水結合物からなるトレハロース、サッカロース等の多糖
類等が好ましく例示できる。これらの内でも取り分けグ
ルコース、ガラクトース、フルクトース、マンニトー
ル、ソルビトール、トレハロース、サッカロース、アラ
ビノース、リボース、デオキシリボース、ラムノース、
及びグリセリンからなる群から選ばれる単糖類又は重合
度2〜3の多糖類を1種又は2種以上用いるのが好まし
い。本発明の組成物において、糖は津液作用を改善する
作用を有する。本発明の津液改善組成物における好まし
い糖類の含有量は、組成物全量に対して0.01〜50
重量%であり、より好ましくは0.1〜30重量%であ
り、更に好ましくは0.5〜20重量%である。Embodiments of the present invention will be described below. The tsutsumo improvement composition of the present invention is characterized by containing a saccharide and a biocompatible lipid as active ingredients. Here, the saccharide may be a generally known saccharide,
For example, glucose, galactose, fructose, arabinose, 3-6 carbon sugars such as ribose and derivatives thereof, specifically, mannitol, sorbitol, sugar alcohols such as glycerin, deoxyribose, deoxy sugars such as rhamnose, glucosamine and the like. Monosaccharides containing carboxyl group-containing sugars such as amino sugars and glucuronic acid and gluconic acid, and polysaccharides such as trehalose and saccharose composed of one or more dehydrated conjugates thereof can be preferably exemplified. Among them, glucose, galactose, fructose, mannitol, sorbitol, trehalose, saccharose, arabinose, ribose, deoxyribose, rhamnose,
It is preferable to use one or more monosaccharides or polysaccharides having a polymerization degree of 2 to 3 selected from the group consisting of glycerol and glycerin. In the composition of the present invention, the saccharide has an effect of improving the essence of the juice. The preferred saccharide content in the tsukumo improvement composition of the present invention is 0.01 to 50 with respect to the total amount of the composition.
%, More preferably 0.1 to 30% by weight, even more preferably 0.5 to 20% by weight.
【0012】本発明における生体親和性脂質とは、細胞
間や神経細胞中などに存在する脂質をいい、これらは生
体の細胞と親和性を有する。このような生体親和性脂質
としては、燐脂質、スフィンゴ燐脂質、及びスフィンゴ
糖脂質が例示できる。燐脂質としては、レシチン、フォ
スファチジルセリン、フォスファチジルイノシトール、
フォスファチジルエタノールアミン、フォスファチジル
グリセロール、フォスファチジン酸、リゾレシチン等の
リゾ燐脂質等が好ましく例示できる。スフィンゴ糖脂質
としては、スフィンゴシンと糖と脂肪酸が結合した、セ
レブロシドやガングリオシド等が好ましく例示できる。
スフィンゴ燐脂質としては、スフィンゴシンと燐酸と脂
肪酸との結合体である、スフィンゴミエリン等が好まし
く例示できる。これら生体親和性脂質は単独で用いても
よいし、2種以上を組み合わせて用いてもよい。又、脳
抽出物等の生体由来物質を混合物のまま用いることも可
能である。これらは、例示したものの多くが既に市販さ
れており、それらを用いることも可能である。本発明の
組成物において、上記生体親和性脂質は、糖が津液改善
の場である真皮内に移行し、津液作用の改善効果が発現
するのを助ける役割を担っていると考えられる。本発明
の組成物における生体親和性脂質の好ましい含有量は、
0.01〜20重量%であり、より好ましくは0.05
〜10重量%であり、更に好ましくは0.1〜5重量%
である。The biocompatible lipid in the present invention refers to a lipid existing between cells or in nerve cells, and has an affinity for living cells. Examples of such a biocompatible lipid include phospholipids, phosphosphingolipids, and glycosphingolipids. Phospholipids include lecithin, phosphatidylserine, phosphatidylinositol,
Preferred examples include lysophospholipids such as phosphatidylethanolamine, phosphatidylglycerol, phosphatidic acid, and lysolecithin. Preferred examples of glycosphingolipids include cerebroside, ganglioside, and the like, in which sphingosine, sugar, and a fatty acid are bound.
Preferable examples of the sphingophospholipid include sphingomyelin, which is a conjugate of sphingosine, phosphoric acid, and a fatty acid. These biocompatible lipids may be used alone or in combination of two or more. It is also possible to use a biological substance such as a brain extract as a mixture. Many of these are already commercially available, and it is also possible to use them. In the composition of the present invention, it is considered that the biocompatible lipid plays a role in assisting the sugar to migrate into the dermis, which is a place for improving the pulp juice, and to exert the effect of improving the pulp juice action. The preferred content of the biocompatible lipid in the composition of the present invention is
0.01 to 20% by weight, more preferably 0.05 to 20% by weight.
10 to 10% by weight, more preferably 0.1 to 5% by weight
It is.
【0013】本発明の組成物は、上記糖類と生体親和性
脂質とを組み合わせることにより津液作用の改善に優れ
た効果を有する。組成物中における糖類と生体親和性脂
質との比率は、重量比として好ましくは1:9〜9:
1、より好ましくは1:3〜3:1である。[0013] The composition of the present invention has an excellent effect on the improvement of the essence by combining the above saccharide and a biocompatible lipid. The ratio of the saccharide to the biocompatible lipid in the composition is preferably 1: 9 to 9:
1, more preferably 1: 3 to 3: 1.
【0014】本発明の組成物においては、必須成分であ
る前記糖類及び生体親和性脂質以外に、化粧料、浴用
剤、皮膚外用医薬品等、本発明の組成物の応用が考えら
れる製剤において通常用いられる各種の任意成分を含有
することができる。このような任意成分としては、例え
ば、ワセリンやマイクロクリスタリンワックス等のよう
な炭化水素類、ホホバ油やゲイロウ等のエステル類、牛
脂、オリーブ油等のトリグリセライド類、セタノール、
オレイルアルコール等の高級アルコール類、ステアリン
酸、オレイン酸等の脂肪酸、ジグリセリンや1,3−ブ
タンジオール等の多価アルコール類、非イオン界面活性
剤、アニオン界面活性剤、カチオン界面活性剤、両性界
面活性剤、エタノール、カーボポール等の増粘剤、防腐
剤、紫外線吸収剤、抗酸化剤、色素、粉体類等が例示で
きる。このような製剤は通常行われている方法に従って
製造することができる。In the composition of the present invention, in addition to the above-mentioned essential sugars and biocompatible lipids, it is usually used in preparations in which the composition of the present invention can be applied, such as cosmetics, bath preparations, and external dermatological drugs. Various optional components can be contained. Such optional components include, for example, hydrocarbons such as petrolatum and microcrystalline wax, esters such as jojoba oil and gay wax, tallow, triglycerides such as olive oil, cetanol,
Higher alcohols such as oleyl alcohol, fatty acids such as stearic acid and oleic acid, polyhydric alcohols such as diglycerin and 1,3-butanediol, nonionic surfactants, anionic surfactants, cationic surfactants, amphoteric Examples include surfactants, thickeners such as ethanol and carbopol, preservatives, ultraviolet absorbers, antioxidants, pigments, and powders. Such a preparation can be produced according to a commonly used method.
【0015】かくして得られる本発明の組成物は、津液
作用の改善に用いられる。好ましくは、化粧料、浴用剤
又は皮膚外用医薬品として用いられる。また、本発明の
組成物は、好ましくは、皮膚疾患治療又は予防用組成物
とすることができる。[0015] The composition of the present invention thus obtained is used for improving the essence of Tsutsumi. Preferably, it is used as a cosmetic, a bath preparation or a skin external medicine. Further, the composition of the present invention can be preferably a composition for treating or preventing skin diseases.
【0016】津液作用は、その発現形態としてしゃ下作
用、利水作用、補陰作用、消導作用として生体に発現す
ることが知られている。これらの作用を有する漢方生薬
としては、しゃ下作用であれば、ダイオウ、バンシャヨ
ウ、ロカイ、マシニン、ケンゴシ、カンスイ、ゲンカ、
ゾクズイシ、ウキュウコンピ等が知られており、利水作
用を有する漢方生薬としては、チョレイ、ブクリョウ、
タクシャ、インチンコウ、ヨクイニン、トウカニン、ジ
フシ、トウキヒ、キンセンソウ等が知られており、補陰
作用を有する漢方生薬としては、シャジン、セイヨウジ
ン、テンモンドウ、バクモンドウ、セッコク、ギョクチ
ク、ヒャクゴウ、ソウキセイ、カンレンソウ、ジョテイ
シ、ゴマ、コクズ、キバン、ベッコウ等が知られてお
り、消導作用を有する漢方生薬としては、サンザシ、ク
レンコンピ、ヒシ、カクシツ、ライガン、ビンロウジ、
ナンカシ、タイサン等が知られている。It is known that the tsuju action is expressed in a living body as a mode of expression, such as a shampooing action, a water-saving action, a prosthesis action, and a conduction action. As a herbal medicine having these effects, if it is a depressant effect, rhubarb, banshayou, rokai, machinin, kengoshi, kansui, genka,
Zokuzi-ishi, kyukyu-compi, and the like are known, and as herbal crude drugs having a water-utilizing effect, chorei, bukuro,
Taksha, chinko, yokuinin, toucanin, difushi, tokhihi, calendula, etc. are known, and as herbal crude drugs having a prominence action, shajin, seijin, tenmondou, bakkumondou, sekikoku, goktyku, zyaku, sukiyase, kanrensou, jyoseishi , Sesame, kokuzuku, kiban, bekko, etc. are known, and as a herbal medicine having an antidepressant action, hawthorn, cren compi, hishi, kakushitsu, ligan, areca,
Nankashi, Taisan and the like are known.
【0017】これらについての文献等を調べてみると、
美肌作用、発毛促進作用、抗アレルギー作用、抗炎症作
用、消化促進作用等の薬理作用が重複していることが見
出された。ここに本発明者等は注目し、「水」(津液)
の作用は現代医学における美肌作用、アトピー性皮膚
炎、湿疹、皮膚真菌症、疣贅、色素沈着症、尋常性乾
癬、老人性乾皮症、老人性角化腫、火傷等の皮膚疾患の
治療作用、発毛促進作用、吹き出物の治療作用、消化液
分泌促進作用、発汗促進作用、利尿作用、便通促進作用
等を指標とすることができることを見出した。尚、これ
らの作用の一つを有する物質は、大なり小なり他の作用
も有している場合が多い。したがって、これらの作用の
一つを指標にするスクリーニングを行えば、他の作用の
推定を行うこともできる。Examining the literature and the like about these,
It has been found that pharmacological actions such as beautifying action, hair growth-promoting action, anti-allergic action, anti-inflammatory action, and digestion promoting action overlap. Here, the present inventors pay attention, and consider "water" (Tsu liquid).
Works in modern medicine to treat skin disorders such as skin beautification, atopic dermatitis, eczema, dermatomycosis, warts, pigmentation, psoriasis vulgaris, senile xeroderma, senile keratoma and burns It has been found that the action, the hair growth promoting action, the therapeutic action of pimples, the digestive juice secretion promoting action, the sweat promoting action, the diuretic action, the bowel movement promoting action and the like can be used as indices. In addition, substances having one of these actions often have other actions to a greater or lesser degree. Therefore, if screening is performed using one of these actions as an index, other actions can be estimated.
【0018】すなわち、本発明の津液改善組成物は、美
肌作用、アトピー性皮膚炎治療作用、湿疹で代表される
皮膚炎群治療作用、皮膚真菌症治療作用、疣贅治療作
用、肝炎で代表される色素沈着症治療作用、尋常性乾癬
治療症、老人性乾皮症、老人性角化腫治療作用、物理的
原因による皮膚損傷治療作用、発毛促進作用、消化液分
泌促進作用、発汗促進作用、便通促進作用、及び排尿促
進(利尿)作用からなる群から選ばれる少なくとも一つ
を改善する作用を有しており、特に美肌作用や、アトピ
ー性皮膚炎、湿疹、皮膚真菌症、疣贅、色素沈着症、尋
常性乾癬、老人性乾皮症、老人性角化腫、火傷等の各種
皮膚疾患の治療作用、発毛促進作用の改善が著しく期待
でき、中でもアトピー性皮膚炎の治療・予防作用が優れ
て期待できる。[0018] That is, the composition of the present invention for improving tanning fluid is represented by the action of beautifying skin, the action of treating atopic dermatitis, the action of treating dermatitis represented by eczema, the action of treating dermatomycosis, the action of treating warts, and hepatitis. Therapeutic action for pigmentation disease, psoriasis vulgaris, senile xeroderma, senile keratoma, skin damage treatment due to physical causes, hair growth promoting action, digestive secretion promoting action, sweat promoting action Has an effect of improving at least one selected from the group consisting of a bowel movement promoting effect and a urination promoting (diuretic) effect, and particularly has a beautiful skin effect, atopic dermatitis, eczema, dermatomycosis, warts, It can be expected to remarkably improve the treatment of various skin diseases such as pigmentation, psoriasis vulgaris, senile xeroderma, senile keratoma, burns, etc., and the improvement of hair growth, especially the treatment and prevention of atopic dermatitis Excellent action can be expected.
【0019】本発明の組成物はいずれの投与経路でも投
与可能であるが、経皮投与が最も改善効果が高く、経皮
投与することにより津液作用を改善する作用に優れる。
更に本発明の組成物としては糖類と生体親和性脂質とを
単一の製剤に含有させ同時に用いることは当然可能であ
るが、別々の少なくとも2種の製剤にどちらか一方又は
両方を含有させ、同時に又は時間を前後して投与するこ
とも可能である。この場合、化粧料と浴用剤、浴用剤と
皮膚外用医薬品等の組み合わせのように、異なった応用
分野のものを組み合わせて投与することも可能である。The composition of the present invention can be administered by any route of administration, but transdermal administration has the highest improvement effect, and transdermal administration is excellent in the effect of improving the essence of the liquor.
Further, it is naturally possible for the composition of the present invention to contain a saccharide and a biocompatible lipid in a single preparation and to use them simultaneously.However, one or both of them are contained in at least two separate preparations, It is also possible to administer them simultaneously or at different times. In this case, it is also possible to administer a combination of different application fields, such as a combination of a cosmetic and a bath preparation, or a bath preparation and a skin external preparation.
【0020】[0020]
【実施例】以下に、本発明の実施例を説明するが、本発
明がこれら実施例のみに限定を受けないことは言うまで
もない。尚、処方の数値は、特に断らない限り総て重量
部を表す。EXAMPLES Examples of the present invention will be described below, but it goes without saying that the present invention is not limited to only these examples. In addition, all numerical values of the prescription represent parts by weight unless otherwise specified.
【0021】[0021]
【実施例1〜5】下記表1に示す処方に従って、乳液を
作成した。即ち、(イ)、(ロ)、(ハ)をそれぞれ8
0℃に加熱溶解又は一様分散し、(イ)に(ロ)を徐々
に加え、更に(ハ)を徐々に加えて粗乳化し、ホモジナ
イザーで均一化し乳液を得た。Examples 1 to 5 Emulsions were prepared according to the formulations shown in Table 1 below. That is, (a), (b), and (c) are each 8
The mixture was dissolved by heating or uniformly dispersed at 0 ° C., (B) was gradually added to (A), and (C) was gradually added to coarsely emulsify and homogenize with a homogenizer to obtain an emulsion.
【0022】[0022]
【表1】 [Table 1]
【0023】[0023]
【実施例6〜10】以下に示す処方に従って、乳液を作
成した。即ち、(イ)、(ロ)、(ハ)をそれぞれ80
℃に加熱溶解又は一様分散し、(イ)に(ロ)を徐々に
加え、更に(ハ)を徐々に加えて粗乳化し、ホモジナイ
ザーで均一化し乳液を得た。Examples 6 to 10 Emulsions were prepared according to the following formulation. That is, (a), (b), and (c) are 80
The mixture was dissolved by heating or uniformly dispersed at ℃, (B) was gradually added to (A), and (C) was gradually added to coarsely emulsify the mixture, and homogenized with a homogenizer to obtain an emulsion.
【0024】[0024]
【表2】 [Table 2]
【0025】[0025]
【実施例11〜15】以下に示す処方に従って、乳液を
作成した。即ち、(イ)、(ロ)、(ハ)をそれぞれ8
0℃に加熱溶解又は一様分散し、(イ)に(ロ)を徐々
に加え、更に(ハ)を徐々に加えて粗乳化し、ホモジナ
イザーで均一化し乳液を得た。Examples 11 to 15 An emulsion was prepared according to the following formulation. That is, (a), (b), and (c) are each 8
The mixture was dissolved by heating or uniformly dispersed at 0 ° C., (B) was gradually added to (A), and (C) was gradually added to coarsely emulsify and homogenize with a homogenizer to obtain an emulsion.
【0026】[0026]
【表3】 [Table 3]
【0027】[0027]
【実施例16〜20】下記処方に従って浴用剤を作成し
た。即ち処方成分をニーダーに秤込み、よく混練し、浴
用剤を得た。Examples 16 to 20 Bath agents were prepared according to the following formulation. That is, the ingredients were weighed into a kneader and kneaded well to obtain a bath agent.
【0028】[0028]
【表4】 [Table 4]
【0029】[0029]
【実施例21】下記処方に従って軟膏を作成した。即
ち、処方成分をニーダーでよく混練りし軟膏を得た。Example 21 An ointment was prepared according to the following formulation. That is, the ingredients were kneaded well with a kneader to obtain an ointment.
【0030】[0030]
【表5】 [Table 5]
【0031】[0031]
【実施例22】 <試験例1:美肌改善作用>肌荒れに悩む21〜52歳
のパネラー1群5名が、上記実施例1〜5の乳液を1日
朝晩2回2ヶ月間患部に塗布し、肌荒れの改善効果を評
価した。評価は、非常に改善した(評点5)〜改善しな
い(評点0)、の基準で評点をつけて行った。対照とし
ては、実施例1の糖類と生体親和性脂質を水に置換した
ものを用いた。結果を平均評点として表6に示す。これ
より、本発明の乳液が肌荒れを改善する作用を有するこ
と、即ち、美肌作用を有することがわかる。これより、
糖類と生体親和性脂質の組み合わせがこのような作用を
有することがわかる。Example 22 <Test Example 1: Improving the beautiful skin> A group of 5 panelists aged 21 to 52 years old suffering from rough skin applied the emulsion of Examples 1 to 5 twice a day, morning and evening to the affected area for 2 months. The effect of improving skin roughness was evaluated. The evaluation was performed on a scale of very improved (score 5) to no improvement (score 0). As a control, the saccharide and the biocompatible lipid of Example 1 were replaced with water. The results are shown in Table 6 as average scores. This indicates that the emulsion of the present invention has an effect of improving rough skin, that is, has a beautiful skin effect. Than this,
It can be seen that a combination of a saccharide and a biocompatible lipid has such an effect.
【0032】[0032]
【表6】 [Table 6]
【0033】[0033]
【実施例23】 <試験例2:発毛促進作用>C3Hマウス1群5匹の背
部を剃毛し、実施例1〜5の乳液200μlを塗布し、
その後の毛の生え方を観察して発毛促進作用を評価し
た。対照は生理食塩水のみとした。また、比較例1とし
て、実施例1のグルコースを水に置換したものを、比較
例2として同じく実施例1のセレブロシドを水に置換し
たものを、比較例3として実施例1のグルコースとセレ
ブロシドの両方を水に置換したものを用いた。評価の基
準は、++(評点4):対照に比べて著しく早い、+
(評点2):対照に比べて早い、±(評点1):対照に
比べてやや早い、−(評点0):対照に比べて早くな
い、とした。結果を平均評点として表7に示す。これよ
り、本発明の有効成分である糖類と生体親和性脂質の組
み合わせは発毛促進作用に優れることがわかる。Example 23 <Test Example 2: Hair growth promoting action> The back of five C3H mice was shaved, and 200 μl of the emulsion of Examples 1 to 5 was applied.
The subsequent hair growth was observed to evaluate the hair growth promoting action. The control was physiological saline only. Further, Comparative Example 1 was obtained by replacing glucose in Example 1 with water, Comparative Example 2 was obtained by replacing the cerebroside of Example 1 by water, and Comparative Example 3 was obtained by combining glucose and cerebroside of Example 1 with water. Both were replaced with water. Evaluation criteria: ++ (score 4): significantly faster than control, +
(Score 2): earlier than the control, ± (score 1): slightly earlier than the control,-(score 0): not earlier than the control. The results are shown in Table 7 as average scores. This indicates that the combination of the saccharide as the active ingredient of the present invention and the biocompatible lipid is excellent in hair growth promoting action.
【0034】[0034]
【表7】 [Table 7]
【0035】[0035]
【実施例24】 <試験例3:アトピー性皮膚炎に対する作用>アトピー
性皮膚炎に悩む20〜42歳のパネラー1群10名が、
上記実施例1〜5の乳液を1日朝晩2回ずつ2ヶ月間患
部に塗布し、アトピー性皮膚炎の改善効果を評価した。
評価は、非常に改善した(評点5)〜改善しない(評点
0)、の基準で評点をつけて行った。対照としては、実
施例1のグルコースとセレブロシドを水に置換したもの
を用いた。結果を平均評点として表8に示す。これよ
り、本発明の乳液はアトピー性皮膚炎を改善する作用を
有することがわかる。即ち、本発明の有効成分である糖
類と生体親和性脂質の組み合わせはこのような作用を有
することがわかる。Example 24 <Test Example 3: Effect on Atopic Dermatitis> Ten groups of panelists aged 20 to 42 years old suffering from atopic dermatitis
The emulsions of Examples 1 to 5 were applied to the affected area twice a day and twice a day for 2 months to evaluate the effect of improving atopic dermatitis.
The evaluation was performed on a scale of very improved (score 5) to no improvement (score 0). As a control, glucose and cerebroside of Example 1 were replaced with water. The results are shown in Table 8 as average scores. This indicates that the emulsion of the present invention has an effect of improving atopic dermatitis. That is, it can be seen that the combination of the saccharide as the active ingredient of the present invention and the biocompatible lipid has such an effect.
【0036】[0036]
【表8】 [Table 8]
【0037】[0037]
【実施例25】 <試験例4:アトピー性皮膚炎に対する作用>アトピー
性皮膚炎に悩む20〜42歳のパネラー1群10名が、
上記実施例16〜20の浴用剤を2カ月間使用し、アト
ピー性皮膚炎の改善効果を評価した。評価は、非常に改
善した(評点5)〜改善しない(評点0)、の基準で評
点をつけて行った。対照としては、実施例16のグルコ
ースとレシチンを硫酸ナトリウムに置換したものを用い
た。結果を平均評点として表9に示す。これより、本発
明の浴用剤はアトピー性皮膚炎を改善する作用を有する
ことがわかる。即ち、本発明の有効成分である糖類と生
体親和性脂質の組み合わせはこのような作用を有するこ
とがわかる。Example 25 <Test Example 4: Effect on Atopic Dermatitis> Ten groups of panelists aged 20 to 42 years old suffering from atopic dermatitis
The bath preparations of Examples 16 to 20 were used for 2 months to evaluate the effect of improving atopic dermatitis. The evaluation was performed on a scale of very improved (score 5) to no improvement (score 0). As a control, glucose and lecithin of Example 16 were replaced with sodium sulfate. The results are shown in Table 9 as average scores. This indicates that the bath preparation of the present invention has an effect of improving atopic dermatitis. That is, it can be seen that the combination of the saccharide as the active ingredient of the present invention and the biocompatible lipid has such an effect.
【0038】[0038]
【表9】 [Table 9]
【0039】[0039]
【実施例26】 <試験例5:創傷治癒作用>ハートレー白色種雌性モル
モット1群6匹を用いて創傷治癒作用を調べた。即ち、
モルモット背部を剃毛し、2cm平方の部位を作成し、
この部位をガムテープで5回ストリッピングし、その2
4時間後に、表10に示す検体を0.05ml投与し
た。検体投与7日後皮膚反応を以下に示すドレーズの基
準で判定し、皮膚反応の平均評点を算出した。結果を表
10に示す。これより、糖類と生体親和性脂質の組み合
わせ効果が明らかである。Example 26 <Test Example 5: Wound healing action> The wound healing action was examined using six Hartley white female guinea pigs per group. That is,
Shaving the back of the guinea pig, creating a 2 cm square area,
This part is stripped five times with a piece of adhesive tape.
Four hours later, 0.05 ml of the sample shown in Table 10 was administered. Seven days after the administration of the sample, the skin reaction was determined according to the Draise criteria shown below, and the average score of the skin reaction was calculated. Table 10 shows the results. This clearly shows the effect of the combination of the saccharide and the biocompatible lipid.
【0040】(ドレーズの判定基準) ++(評点2):浮腫又は痂皮を伴う反応、+(評点
1):明らかな紅斑反応又は色素沈着、±(評点0.
5):疑わしい紅斑反応又は色素沈着、−(評点0):
無反応(Draise criterion) ++ (score 2): reaction with edema or eschar, + (score 1): obvious erythema reaction or pigmentation, ± (score 0.
5): Suspicious erythema reaction or pigmentation,-(score 0):
no reaction
【0041】[0041]
【表10】 [Table 10]
【0042】[0042]
【実施例27】下記表11に示す処方の浴用剤を作成し
た。すなわち、表11記載の処方成分を表11記載の割
合で混合してニーダーで練って、50gずつ小分けし、
袋に詰めて浴用剤とした。このものを便秘に悩む39歳
の女性に処方し、1週間使用させたところ、使用開始3
日後に便通を見、5日目より一日一回定期的な便通を経
験するようになった。Example 27 Bath agents having the formulations shown in Table 11 below were prepared. That is, the ingredients listed in Table 11 were mixed in the proportions shown in Table 11, kneaded with a kneader, and divided into 50 g portions.
It was packed in a bag to make a bath agent. This product was prescribed to a 39-year-old woman suffering from constipation and used for one week.
He saw bowel movements a day later and began to experience regular bowel movements once a day from the fifth day.
【0043】[0043]
【表11】 [Table 11]
【0044】[0044]
【実施例28】下記表12に示す処方の浴用剤を作成し
た。すなわち、表12記載の処方成分を表12記載の割
合で混合してニーダーで練って、50gずつ小分けし、
袋に詰めて浴用剤とした。このものを便秘に悩む42歳
の女性に処方し、2週間使用させたところ、使用開始5
日後に便通が改善し始め(量が増え)、8日後より2日
に1回定期的な、比較的に量も多い便通を経験するよう
になり、腹部の膨張感もとれた。Example 28 A bath agent having the formulation shown in Table 12 below was prepared. That is, the ingredients shown in Table 12 were mixed in the proportions shown in Table 12, kneaded with a kneader, and divided into 50 g portions.
It was packed in a bag to make a bath agent. This product was prescribed to a 42-year-old woman suffering from constipation and used for 2 weeks.
After days, the bowel movement began to improve (increased volume), and after eight days, she began to experience a relatively large amount of bowel movements once every two days, and the abdominal swelling was felt.
【0045】[0045]
【表12】 [Table 12]
【0046】[0046]
【発明の効果】本発明によれば、美肌作用、アトピー性
皮膚炎等の皮膚疾患の治療又は予防作用、発毛促進作用
等の津液作用の改善効果に優れた化粧料、皮膚外用医薬
品、浴用剤等の組成物を提供することができる。EFFECTS OF THE INVENTION According to the present invention, cosmetics, external medicines for skin, and baths which are excellent in the effect of improving skin essence, the treatment or prevention of skin diseases such as atopic dermatitis, and the like, and the improvement of the tsukusu effect such as the promotion of hair growth. A composition such as an agent can be provided.
───────────────────────────────────────────────────── フロントページの続き (72)発明者 安藤 信裕 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (72)発明者 村松 宜江 神奈川県横浜市神奈川区高島台27番地1 ポーラ化成工業株式会社横浜研究所内 (72)発明者 河合 充夫 神奈川県横浜市戸塚区柏尾町560 ポーラ 化成工業株式会社戸塚研究所内 ──────────────────────────────────────────────────続 き Continuing on the front page (72) Inventor Nobuhiro Ando 27-1, Takashimadai, Kanagawa-ku, Yokohama-shi, Kanagawa Prefecture Inside the Yokohama Laboratory, Polar Chemical Industry Co., Ltd. (72) Inventor Yoshie Muramatsu 27, Takashimadai, Kanagawa-ku, Yokohama-shi, Kanagawa Address 1 Inside the Polar Research Kasei Kogyo Co., Ltd. Yokohama Research Laboratory (72) Inventor Mitsuo Kawai 560 Kashio-cho, Totsuka-ku, Yokohama-shi, Kanagawa Pref.
Claims (9)
る、津液作用の改善に用いられる津液改善組成物。Claims: 1. A tsumumo-improving composition for use in improving tsumumo action, comprising a saccharide and a biocompatible lipid as active ingredients.
ス、フルクトース、マンニトール、ソルビトール、トレ
ハロース、サッカロース、アラビノース、リボース、デ
オキシリボース、ラムノース及びグリセリンからなる群
から選ばれる1種又は2種以上を含有する、請求項1記
載の津液改善組成物。2. The saccharide contains one or more selected from the group consisting of glucose, galactose, fructose, mannitol, sorbitol, trehalose, saccharose, arabinose, ribose, deoxyribose, rhamnose and glycerin. 2. The composition according to 1 above.
ンゴ燐脂質、及びスフィンゴ糖脂質からなる群から選ば
れる1種又は2種以上を含有する、請求項1又は2記載
の津液改善組成物。3. The composition according to claim 1, wherein the biocompatible lipid contains one or more selected from the group consisting of phospholipids, phosphosphingolipids, and glycosphingolipids.
求項1〜3のいずれかに記載の津液改善組成物。4. The composition according to claim 1, which is an external preparation for skin.
又は浴用剤である、請求項4記載の津液改善組成物。5. The composition according to claim 4, wherein the skin preparation is a cosmetic, a skin preparation or a bath preparation.
防作用、発毛促進作用、又は美肌作用である、請求項1
〜5のいずれかに記載の津液改善組成物。6. The method according to claim 1, wherein the essence is a therapeutic or preventive action for skin diseases, a hair growth promoting action, or a beautiful skin effect.
6. The tsutsumo improvement composition according to any one of items 1 to 5.
求項6記載の津液改善組成物。7. The composition according to claim 6, wherein the skin disease is atopic dermatitis.
る、皮膚疾患治療又は予防用組成物。8. A composition for treating or preventing a skin disease, comprising a saccharide and a biocompatible lipid as active ingredients.
求項8記載の組成物。9. The composition according to claim 8, wherein the skin disease is atopic dermatitis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP26052497A JPH10175868A (en) | 1996-10-18 | 1997-09-25 | Water (of chinese medicine idea) improving composition |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP8-276660 | 1996-10-18 | ||
JP27666096 | 1996-10-18 | ||
JP26052497A JPH10175868A (en) | 1996-10-18 | 1997-09-25 | Water (of chinese medicine idea) improving composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH10175868A true JPH10175868A (en) | 1998-06-30 |
Family
ID=26544641
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP26052497A Pending JPH10175868A (en) | 1996-10-18 | 1997-09-25 | Water (of chinese medicine idea) improving composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH10175868A (en) |
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11255617A (en) * | 1998-03-10 | 1999-09-21 | Pola Chem Ind Inc | Makeup cosmetic for improving skin condition |
JP2000103718A (en) * | 1998-09-28 | 2000-04-11 | Pola Chem Ind Inc | Composition for improving activity of living body |
JP2000143437A (en) * | 1998-11-09 | 2000-05-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing huhectant vegetable extract |
JP2005298503A (en) * | 2004-04-07 | 2005-10-27 | Amorepacific Corp | Moisture-retention cosmetic composition containing pulverized polygonatum offcinale |
WO2007034927A1 (en) * | 2005-09-22 | 2007-03-29 | Snow Brand Milk Products Co., Ltd. | Medicine, food and drink or feed containing sphingomyelin |
JP2007112793A (en) * | 2005-09-22 | 2007-05-10 | Snow Brand Milk Prod Co Ltd | Sphingomyelin-containing medicine, food and drink or fodder |
JP2007186447A (en) * | 2006-01-12 | 2007-07-26 | Japan Royal Jelly Co Ltd | Bath preparation |
JP2012167104A (en) * | 2005-09-22 | 2012-09-06 | Snow Brand Milk Products Co Ltd | Sphingomyelin-containing medicine |
-
1997
- 1997-09-25 JP JP26052497A patent/JPH10175868A/en active Pending
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH11255617A (en) * | 1998-03-10 | 1999-09-21 | Pola Chem Ind Inc | Makeup cosmetic for improving skin condition |
JP2000103718A (en) * | 1998-09-28 | 2000-04-11 | Pola Chem Ind Inc | Composition for improving activity of living body |
JP2000143437A (en) * | 1998-11-09 | 2000-05-23 | Ichimaru Pharcos Co Ltd | Cosmetic composition containing huhectant vegetable extract |
JP2005298503A (en) * | 2004-04-07 | 2005-10-27 | Amorepacific Corp | Moisture-retention cosmetic composition containing pulverized polygonatum offcinale |
WO2007034927A1 (en) * | 2005-09-22 | 2007-03-29 | Snow Brand Milk Products Co., Ltd. | Medicine, food and drink or feed containing sphingomyelin |
JP2007112793A (en) * | 2005-09-22 | 2007-05-10 | Snow Brand Milk Prod Co Ltd | Sphingomyelin-containing medicine, food and drink or fodder |
AU2006293026B2 (en) * | 2005-09-22 | 2012-08-16 | Megmilk Snow Brand Co., Ltd. | Medicine, food and drink or feed containing sphingomyelin |
JP2012167104A (en) * | 2005-09-22 | 2012-09-06 | Snow Brand Milk Products Co Ltd | Sphingomyelin-containing medicine |
US8486916B2 (en) | 2005-09-22 | 2013-07-16 | Megmilk Snow Brand Co., Ltd. | Medicine, food and drink or feed containing sphingomyelin |
US9186366B2 (en) | 2005-09-22 | 2015-11-17 | Megmilk Snow Brand Co., Ltd. | Medicine, food and drink or feed containing sphingomyelin |
JP2007186447A (en) * | 2006-01-12 | 2007-07-26 | Japan Royal Jelly Co Ltd | Bath preparation |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0802515B1 (en) | cosmetic use and use of at least one vitreoscilla filiformis bacterial extract, composition and non-therapeutic cosmetic treatment process | |
KR20180036580A (en) | Composition for prevention or treatment of inflammatory skin diseases or severe pruritus comprising the aqueous solubilized ursodeoxycholic acid | |
BRPI0808065B1 (en) | NEW COSMETIC AND / OR PHARMACEUTICAL COMPOSITIONS AND THEIR APPLICATIONS | |
WO2009049172A1 (en) | Methods and compositions for treating dermatological diseases and conditions | |
JP2000513706A (en) | Skin care formulations and methods | |
JP2003518066A (en) | Compositions containing oligosaccharides, especially cosmetic or dermatological compositions, methods for their preparation and methods for cosmetic treatment | |
EP2763686A1 (en) | Composition for the treatment of skin lesions | |
JPH0873342A (en) | Skin external preparation or bathing agent containing rubi fructus extract | |
JP2557240B2 (en) | Skin anti-aging agent | |
JP2005082600A (en) | Method for treating skin condition | |
JPH10175868A (en) | Water (of chinese medicine idea) improving composition | |
JP2008088075A (en) | Profilaggrin/filaggrin production promoter, epidermal keratinocyte proliferation promoter, skin care preparation for normalizing epidermis/horny cell layer, profilaggrin/filaggrin production-promoting method and epidermal keratinocyte proliferation-promoting method | |
DE69312887T2 (en) | Lanolin / wool fatty acid ester as a skin treatment agent | |
JPH10120579A (en) | Skin preparation for improving sputum for external use | |
JPH10175859A (en) | External preparation for skin for improving water (of chinese medicine idea) | |
KR101761005B1 (en) | Cosmetic composition containing non-toxic sulfur for sikn moisture, anti-inflammatory and immune enhancement and manufacturing the same | |
JPH05262635A (en) | Dermatic external preparation | |
JPH10175854A (en) | External preparation for skin for improving water (of chinese medicine idea) | |
KR101558177B1 (en) | Composition for antiobesity and cellulite reduction comprising Ishige okamurae extract | |
JPH10120558A (en) | Skin preparation for improving sputum for external use | |
KR101446706B1 (en) | Composition for skin rejuvenation comprising FGF | |
JP3073862B2 (en) | Hyaluronic acid production promoter | |
JP4018764B2 (en) | Skin preparation for improving tsunami | |
JPH107581A (en) | Arginase activity promoter | |
JPH10120561A (en) | Skin preparation for improving sputum for external use |